Pai, K.S.R. 2026. Molecular docking and simulation studies of FDA approved drugs targeting Allosteric inhibition of Glycogen synthase kinase-3β . Jordan Journal of Pharmaceutical Sciences. 19, 1 (Mar. 2026), 52–70. DOI:https://doi.org/10.35516/jjps.v19i2.2906.